The balance of regulatory and stimulatory B cell subsets in breast cancer draining lymph nodes correlates with tumor prognostic factors.

作者: Sahar Shariati , Fereshteh Mehdipour , Morteza Samadi , Reza Rasolmali , Abdol-Rasoul Talei

DOI: 10.1016/J.LFS.2020.118117

关键词: CancerCD80LymphRegulatory B cellsBiologyCancer researchB cellImmune systemBreast cancerAxillary lymph nodes

摘要: Abstract Aims B cells can promote or inhibit immune responses against breast cancer. We investigated changes in the frequency of with stimulatory regulatory capacity tumor draining lymph nodes during cancer progression. Main methods isolated mononuclear from fresh axillary (LNs) 44 patients and stained lymphocytes antibodies CD19, CD80, CD86, CD39 CD73. To assess programmed death-1 (PD-1) PD-ligand 1 (PD-L1) expression, were briefly stimulated, for PD-1 PD-L1, examined flow cytometry. Key findings The CD80+ was higher nonmetastatic nodes, while percentage CD86+ showed a positive relationship grade numbers involved LNs. A small proportion unstimulated expressed PD-L1 but these molecules rapidly upregulated on following activation. stimulated PD-L1+ an inverse association estrogen progesterone receptor expression nonsignificant grade. In addition, PD-1+ higher-grade tumors. CD73 associated lower LNs, CD39+ larger Significance CD86+, CD39+, associations poor prognostic factors, therefore their potential role suppression should be evaluated greater detail.

参考文章(33)
Xiao Xiao, Xiang-Ming Lao, Min-Min Chen, Rui-Xian Liu, Yuan Wei, Fang-Zhu Ouyang, Dong-Ping Chen, Xiao-Yu Zhao, Qiyi Zhao, Xue-Feng Li, Chuan-Lu Liu, Limin Zheng, Dong-Ming Kuang, PD-1hi Identifies a Novel Regulatory B-cell Population in Human Hepatoma That Promotes Disease Progression Cancer Discovery. ,vol. 6, pp. 546- 559 ,(2016) , 10.1158/2159-8290.CD-15-1408
Robert G Schaut, Ian M Lamb, Angela J Toepp, Benjamin Scott, Carolina O Mendes-Aguiar, Jose FV Coutinho, Selma Jeronimo, Mary E Wilson, John T Harty, Thomas J Waldschmidt, Christine A Petersen, Regulatory IgDhi B Cells Suppress T Cell Function via IL-10 and PD-L1 during Progressive Visceral Leishmaniasis. Journal of Immunology. ,vol. 196, pp. 4100- 4109 ,(2016) , 10.4049/JIMMUNOL.1502678
Honggeng Guan, Yuqiu Wan, Jing Lan, Qin Wang, Zhangyu Wang, Yecheng Li, Jiqing Zheng, Xueguang Zhang, Zemin Wang, Yueping Shen, Fang Xie, PD-L1 is a critical mediator of regulatory B cells and T cells in invasive breast cancer. Scientific Reports. ,vol. 6, pp. 35651- 35651 ,(2016) , 10.1038/SREP35651
Minghui Zhang, Houbin Sun, Shu Zhao, Yan Wang, Haihong Pu, Yan Wang, Qingyuan Zhang, Expression of PD-L1 and prognosis in breast cancer: a meta-analysis. Oncotarget. ,vol. 8, pp. 31347- 31354 ,(2017) , 10.18632/ONCOTARGET.15532
Jieyao Li, Liping Wang, Xinfeng Chen, Lifeng Li, Yu Li, Yu Ping, Lan Huang, Dongli Yue, Zhen Zhang, Fei Wang, Feng Li, Li Yang, Jianmin Huang, Shuangning Yang, Hong Li, Xuan Zhao, Wenjie Dong, Yan Yan, Song Zhao, Bo Huang, Bin Zhang, Yi Zhang, CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer. OncoImmunology. ,vol. 6, ,(2017) , 10.1080/2162402X.2017.1320011
Anushruti Sarvaria, J Alejandro Madrigal, Aurore Saudemont, B cell regulation in cancer and anti-tumor immunity Cellular & Molecular Immunology. ,vol. 14, pp. 662- 674 ,(2017) , 10.1038/CMI.2017.35
Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès–Fridman, Guido Kroemer, The immune contexture in cancer prognosis and treatment Nature Reviews Clinical Oncology. ,vol. 14, pp. 717- 734 ,(2017) , 10.1038/NRCLINONC.2017.101
Fereshteh Mehdipour, Mahboobeh Razmkhah, Zahra Faghih, Mandana Bagheri, Abdol-Rasoul Talei, Abbas Ghaderi, The significance of cytokine-producing B cells in breast tumor-draining lymph nodes. Cellular Oncology. ,vol. 42, pp. 381- 395 ,(2019) , 10.1007/S13402-019-00433-3
Abbas Ghaderi, Fereshteh Mehdipour, Atri Ghods, Mahmoud Shariat, Abdoul-Rasoul Talei, Mohsen Arabpour, Correlation of 4-1BBL+ B Cells in Tumor Draining Lymph Nodes with Pathological Characteristics of Breast Cancer Iranian Journal of Immunology. ,vol. 16, pp. 108- 116 ,(2019) , 10.22034/IJI.2019.80254